Aardvark Therapeutics
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4370 La Jolla Village Dr Ste 1050, San D...Phone Number
(858) 225-7696Website
www.aardvarktherapeutics.comRevenue
$7 MillionStock Symbol
AARDIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Aardvark Therapeutics
Founded in 2017, Aardvark Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing novel small molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, inflammation, and other indications. The company is headquartered in San Diego, California.Explore more
Aardvark Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aardvark Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Aardvark Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Aardvark Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Aardvark Therapeutics has new funding data
Product Launch: Get notified when Aardvark Therapeutics launches new products
Check out if Aardvark Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Aardvark Therapeutics
Aardvark Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Aardvark Therapeutics had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Aardvark Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Aardvark Therapeutics
Compare insights from companies similar to Aardvark Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aardvark Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aardvark Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aardvark Therapeutics.
Aardvark Therapeutics financials insights
Gather financial insights about Aardvark Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$15M
2021
Series B
$29M
2024
Series C
$85M
2025
Stock Offering
$94M
Aardvark Therapeutics Tech Stack
A closer look at the technologies used by Aardvark Therapeutics
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Promotion
Executive Move
Executive Moves, Promotion
Project
Research & Development, Pharmaceuticals, Clinical Operations, Patient Experience
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aardvark Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2017, Aardvark Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing novel small molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, inflammation, and other indications. The company is headquartered in San Diego, California.... Read More
